Cargando…
Inhibitors of bacterial protease enzymes for periodontal therapy
Locally applied therapeutic agents have become established in the treatment of periodontal disease. Inhibition of human metalloproteases by metal‐chelating antibiotics contributes to the utility of local therapy. Adding inhibitors of bacterial proteases might extend and improve local therapy. The pe...
Autores principales: | Hosn, Kalid N., Jefferson, Mary Margaret, Leding, Carlton, Shokouh‐Amiri, Solomon, Thomas, Edwin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839262/ https://www.ncbi.nlm.nih.gov/pubmed/29744136 http://dx.doi.org/10.1002/cre2.4 |
Ejemplares similares
-
Role of salivary leukocyte protease inhibitor in periodontal disease progression
por: Pateel, Deepak, et al.
Publicado: (2010) -
Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines
por: Svensson, Daniel, et al.
Publicado: (2017) -
Potential Simultaneous Inhibitors of Angiotensin-Converting Enzyme 2 and Transmembrane Protease, Serine 2
por: Wu, Ching-Yuan, et al.
Publicado: (2020) -
Modulation of the Epithelial Sodium Channel (ENaC) by Bacterial Metalloproteases and Protease Inhibitors
por: Butterworth, Michael B., et al.
Publicado: (2014) -
Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
por: Musana, Hellen, et al.
Publicado: (2021)